Your browser doesn't support javascript.
loading
Health care factors associated with survival among women with breast cancer on hormone therapy in Rio de Janeiro, Brazil, 2004 – 2010 / Factores de la atención de salud asociados con la supervivencia de las mujeres con cáncer de mama que siguen hormonoterapia en Río de Janeiro, Brasil, 2004-2010
Rev Panam Salud Publica ; 39(6),jun. 2016
Artigo em Inglês | PAHO-IRIS | ID: phr-28542
Biblioteca responsável: US1.1
ABSTRACT
Objectives. To better understand the role that health care plays in breast cancer survival by investigating the effects that hormone therapy adherence and other select health care variables, adjusted for clinical and sociodemographic factors, had among a population of women in Rio de Janeiro, Brazil. Methods. This was a longitudinal study based on secondary data of 5 861 women treated with hormone therapy (tamoxifen or aromatase inhibitors) at the National Cancer Institute of Brazil (INCA), from 1 January 2004 – 29 October 2010. Four different sources of data were integrated for

analysis:

INCA Pharmacy Sector Dispensation System; Hospital-based Cancer Registry; Integrated Hospital System and INCA Absolute System; and Mortality Information System. Analyses explored the effects of adherence to hormone therapy, disease care aspects, and sociodemographic, behavioral, and clinical variables, on the time of survival, using Kaplan- Meier and Cox proportional hazards models. Results. The general survival rate was 94% in the first year after initiation of hormone therapy, and 71% in the fifth year. The Cox model indicated a higher hazard of death among women smokers, with more hospitalizations, more exams, and, among those who used, who used only aromatase inhibitors, as hormone therapy modality. The hazard was lower among women with a partner (stable relationship), a high school or college education a family history of cancer, and those who were treated by a mastologist, oncologist, and/or psychotherapist, who underwent surgery, and who adhered to hormone therapy. Conclusions. The study indicated more vulnerable sub-groups and the aspects of care that provide best results, bringing new knowledge to improve assistance to this group of women.
Assuntos
Texto completo: Disponível Coleções: Bases de dados de organismos internacionais Contexto em Saúde: Agenda de Saúde Sustentável para as Américas Problema de saúde: Objetivo 6: Sistemas de informação em saúde Base de dados: PAHO-IRIS Assunto principal: Qualidade da Assistência à Saúde / Brasil / Neoplasias da Mama / Análise de Sobrevida / Saúde da Mulher / Cooperação do Paciente / Antineoplásicos Hormonais / Usos Terapêuticos / Hormônios Tipo de estudo: Estudo observacional / Estudo prognóstico / Fatores de risco País/Região como assunto: América do Sul / Brasil Idioma: Inglês Ano de publicação: 2016 Tipo de documento: Artigo
Texto completo: Disponível Coleções: Bases de dados de organismos internacionais Contexto em Saúde: Agenda de Saúde Sustentável para as Américas Problema de saúde: Objetivo 6: Sistemas de informação em saúde Base de dados: PAHO-IRIS Assunto principal: Qualidade da Assistência à Saúde / Brasil / Neoplasias da Mama / Análise de Sobrevida / Saúde da Mulher / Cooperação do Paciente / Antineoplásicos Hormonais / Usos Terapêuticos / Hormônios Tipo de estudo: Estudo observacional / Estudo prognóstico / Fatores de risco País/Região como assunto: América do Sul / Brasil Idioma: Inglês Ano de publicação: 2016 Tipo de documento: Artigo
...